1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Immune Checkpoint Inhibitors: new trials by email Literature Review of Immune Checkpoint Inhibitors trials Research Report on Immune Checkpoint Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer Tislelizumab, Oxaliplatin, Capecitabine - Colonic Neoplasms, Neoadjuvant Therapy | Phase 3 | Not yet recruiting | First Affiliated Hospital of Guangxi Medical University | 94 | 2025-10-01 | 2025-08-20 |
| Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer Electroacupuncture combined with immunotherapy, Zilongjin tablet combined with immunotherapy, Immunotherapy - Non-Small Cell Lung Cancer, Electroacupuncture | Phase 2 / Phase 3 | Recruiting | Kong Fanming | 405 | 2025-01-01 | 2025-06-24 |
| The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies Gemcitabine-based chemotherapy regimen combined with immunocheckpoint inhibitors - Gemcitabine, Biliary Tract Cancer | Phase 2 / Phase 3 | Unknown | First People's Hospital of Hangzhou | 50 | 2022-08-01 | 2022-08-04 |
Biliary Tract Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1)
Neoplasms (3) · Neoplasms by Site (3) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Biliary Tract Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1)
Capecitabine (1) · Immunotherapy (1) · Oxaliplatin (1) · tislelizumab (1)
First Affiliated Hospital of Guangxi Medical University (1) · First People's Hospital of Hangzhou (1) · Kong Fanming (1)
China (3)
Sen Zhang (1)